Biotech Values

[mcbio]

Amgen Inc, Merck & Co, Alnylam Pharmaceuticals Inc and a partnership between Bristol-Myers Squibb Co and Isis Pharmaceuticals Inc are in hot pursuit, with rival drugs of their own.

If I were to play the PCSK9 field, I think I'd do that via ALNY given how we've talked in the past about how the shares seem to be really depressed. REGN has had a heck of a run and now sports over a $5B market cap. Maybe this news makes ALNY shares look a little more enticing?